Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06034561
Title Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Instituto do Cancer do Estado de São Paulo
Indications
Therapies
Age Groups: child | adult
Covered Countries BRA

Facility Status City State Zip Country Details
Instituto do Cancer do Estado de Sao Paulo RECRUITING São Paulo SP 01246000 Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field